×
About 16,990 results

ALLMedicine™ Dengue Center

Research & Reviews  6,067 results

Immunoassay for quantification of antigen-specific IgG fucosylation.
https://doi.org/10.1016/j.ebiom.2022.104109
EBioMedicine Šuštić T, Van Coillie J et. al.

Jun 26th, 2022 - Immunoglobulin G (IgG) antibodies serve a crucial immuno-protective function mediated by IgG Fc receptors (FcγR). Absence of fucose on the highly conserved N-linked glycan in the IgG Fc domain strongly enhances IgG binding and activation of myeloi...

A recent chikungunya outbreak associated with the occurrence of Aedes vectors (Diptera:...
https://doi.org/10.1016/j.parint.2022.102613
Parasitology International; Siam HA, Elaagip A et. al.

Jun 26th, 2022 - Aedes aegypti and Ae. albopictus (Diptera: Culicidae) are primary vectors of human arboviral diseases such as dengue, chikungunya, yellow fever, and Zika viruses. Aedes aegypti is well distributed in Sudan, except in Northern and Khartoum states, ...

Structure of the Dengue Virus RNA Promoter.
https://doi.org/10.1261/rna.079197.122
RNA (New York, N.Y.); Sun YT, Varani G

Jun 25th, 2022 - Dengue virus, a single-stranded positive sense RNA virus, is the most prevalent mosquito-borne pathogen in the world. Like all RNA viruses, it uses conserved structural elements within its genome to control essential replicative steps. A 70 nucleo...

Impact of Plantation Induced Forest Degradation on the Outbreak of Emerging Infectious ...
https://doi.org/10.3390/ijerph19127036
International Journal of Environmental Research and Publi... Saha K, Ghatak D et. al.

Jun 25th, 2022 - The world has been facing a pandemic owing to COVID-19. We have also seen the geographic expansion and outbreaks of other emerging infectious diseases (EID) in recent years. This paper investigates the direct and indirect effects of land use land ...

Dengue Seroprevalence and Factors Associated with Dengue Seropositivity in Petaling Dis...
https://doi.org/10.3390/ijerph19127170
International Journal of Environmental Research and Publi... Ng RJ, Chong ZL et. al.

Jun 25th, 2022 - Dengue virus (DENV) infection is a major public health concern, posing huge economic and disease burdens globally. In Malaysia, the incidence of DENV infections has increased significantly over the years. Nevertheless, the passive surveillance mec...

see more →

Guidelines  3 results

Dengue and Zika Virus Diagnostic Testing for Patients with a Clinically Compatible Illn...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581290
MMWR. Recommendations and Reports : Morbidity and Mortali... Sharp TM, Fischer M et. al.

Jun 14th, 2019 - Dengue and Zika viruses are closely related mosquitoborne flaviviruses with similar transmission cycles, distribution throughout the tropics and subtropics, and disease manifestations including fever, rash, myalgia, and arthralgia. For patients wi...

Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Deng...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2982842
PLoS Neglected Tropical Diseases; Beatty ME, Stone A et. al.

Nov 26th, 2010 - Dengue fever is a virus infection that is spread by the Aedes aegypti mosquito and can cause severe disease especially in children. Dengue fever is a major problem in tropical and sub-tropical regions of the world. We invited dengue experts from a...

"Guidelines for the clinical evaluation of dengue vaccines in endemic areas": summary o...
https://doi.org/10.1016/j.vaccine.2008.05.058
Vaccine Edelman R, Hombach J

Jul 4th, 2008 - There is a pressing need for guidelines focused on the clinical evaluation of dengue vaccines in exposed populations, because Phase 1 and 2 clinical trials of dengue vaccines have begun, and Phase 3 field trials may be warranted soon. In response ...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  258 results

Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in Children
https://clinicaltrials.gov/ct2/show/NCT03534245

Jun 24th, 2022 - Mosquito-borne viruses continue to cause significant global morbidity and mortality, particularly in Southeast Asia. When mosquitoes deliver the virus into the skin of humans while probing for a blood meal, they deposit also saliva, which contains...

Village Malaria Worker Expansion
https://clinicaltrials.gov/ct2/show/NCT05045547

Jun 22nd, 2022 - This is an integration of activities with the South and Southeast Asian Community-based Trials Network (SEACTN) that is ongoing in Lao PDR and Bangladesh. The SEACTN study aims to identify the most relevant ways in which village health worker role...

University of Utah COVID-19 Hydrochloroquine Trial
https://clinicaltrials.gov/ct2/show/NCT04342169

Jun 21st, 2022 - Background COVID-19 is pandemic with high mortality among hospitalized patients despite a benign course in the large majority of patients infected. Limited data are available from small outpatient studies and have not shown efficacy in preventing ...

Randomized Trial to Evaluate the Efficacy of Deploying Genetically-engineered Mosquitos to Control Dengue Burden in the City of Sao Jose do Rio Preto, Brazil
https://clinicaltrials.gov/ct2/show/NCT04514107

Jun 21st, 2022 - Study Design Introduction:This will be a parallel design cluster randomized controlled trial with 3 years (3 seasons) of follow-up from initial deployment of mosquitoes. The intervention will be routine control measures, as recommended by the Braz...

Dengue 3 Human Infection Model (DENV-3)
https://clinicaltrials.gov/ct2/show/NCT04298138

Jun 13th, 2022 - Healthy subjects between 18 and 45 years old will be inoculated with Dengue 3 Live Virus Human Challenge (DENV-3-LVHC) in a dose ranging study. Subjects will be closely monitored for the first 28 days with continued follow up through 6 months. Cli...

see more →

News  455 results

GSK, Novartis Pledge Funds for Neglected Tropical Diseases
https://www.medscape.com/viewarticle/976095

Jun 24th, 2022 - LONDON (Reuters) - GSK and Novartis reinforced commitments on Thursday to tackle neglected tropical diseases, as world leaders and health experts gather in Rwanda to discuss ways to better combat illnesses affecting more than a billion people, mos...

What Are the Signs of Post-Acute Infection Syndromes?
https://www.medscape.com/viewarticle/975826

Jun 17th, 2022 - The long-term health consequences of COVID-19 have refocused our attention on post-acute infection syndromes (PAIS), starting a discussion on the need for a complete understanding of multisystemic pathophysiology, clinical indicators, and the epid...

Takeda Says Dengue Vaccine Candidate Works Without Big Safety Risks
https://www.medscape.com/viewarticle/975354

Jun 9th, 2022 - Drugmaker Takeda announced Thursday that its dengue vaccine candidate, TAK-003, prevented 84% of hospitalized dengue cases and 61% of symptomatic cases in 4.5 years of follow-up during its phase 3 TIDES trial. Critically importantly, they identifi...

How Do We Distinguish Between Viral and Bacterial Meningitis?
https://www.medscape.com/viewarticle/972699

Apr 25th, 2022 - This article was originally published in Portuguese on Medscape . Bacteria and viruses are the leading causes of community-acquired meningitis. Bacterial meningitis is associated with high morbidity and mortality, and prompt treatment with appropr...

Former Takeda Vaccine Chief to Lead New COVID Antiviral Venture Aerium
https://www.medscape.com/viewarticle/970702

Mar 23rd, 2022 - CHICAGO (Reuters) - Aerium Therapeutics, a venture-backed startup, on Tuesday announced industry veteran Rajeev Venkayya will lead the company and released data that showed its two experimental monoclonal antibodies neutralized coronavirus variant...

see more →

Patient Education  12 results see all →